KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $162.4 million.

  • Novavax's Shares Outstanding (Weighted Average) rose 143.96% to $162.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.4 million, marking a year-over-year increase of 143.96%. This contributed to the annual value of $152.2 million for FY2024, which is 5103.01% up from last year.
  • Latest data reveals that Novavax reported Shares Outstanding (Weighted Average) of $162.4 million as of Q3 2025, which was up 143.96% from $162.0 million recorded in Q2 2025.
  • Novavax's 5-year Shares Outstanding (Weighted Average) high stood at $162.4 million for Q3 2025, and its period low was $73.0 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $109.1 million, with a median of $89.4 million in 2023.
  • As far as peak fluctuations go, Novavax's Shares Outstanding (Weighted Average) surged by 6604.26% in 2024, and later skyrocketed by 143.96% in 2025.
  • Novavax's Shares Outstanding (Weighted Average) (Quarter) stood at $74.4 million in 2021, then grew by 5.08% to $78.2 million in 2022, then rose by 28.89% to $100.8 million in 2023, then skyrocketed by 51.03% to $152.2 million in 2024, then grew by 6.68% to $162.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $162.4 million in Q3 2025, compared to $162.0 million in Q2 2025 and $161.0 million in Q1 2025.